Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Transcription profiling of Pseudomonas treated with azithromycin-treated vs. untreated


ABSTRACT: Experimental Design; Type of experiment:; In order to evaluate the influence of subinhibitory concentrations of the macrolide antibiotic Azithromycin (AZM) on the global Pseudomonas aeruginosa gene expression, we performed a comparative gene expression analysis of AZM-treated versus untreated P. aeruginosa PAO1 cultures. Experimental factors:; P. aeruginosa PAO1 cultures with and without addition of 2 µg/ ml AZM were grown until early stationary phase. Total RNA was extracted when the cultures reached an OD600 of 2.8. The transcriptomes of the untreated cultures were taken as reference values. Both of the AFFYMETRIX Chips of AZM-treated PAO1 (GSM45590, GSM45591) were compared with each of the two chips of the untreated PAO1 (GSM45588, GSM45589). Hybridization procedures and parameters:; Hybridization of the probes was carried out according to the manufacturer’s “Expression Analysis Protocol (p. 25: Modified Fluidic Protocol for P. aeruginosa cDNA Assay)”, see http://www.affymetrix.com:; Hybridization for 16 h at 50°C and 60 rpm. - Post Hyb Wash 1: 10 cycles of 2 mixes/cycle with Wash Buffer A at 25°C; - Post Hyb Wash 2: 4 cycles of 15 mixes/cycle with Wash Buffer B at 50°C; - Stain: Stain the probe array for 10 minutes in Streptavidin Solution Mix at 25°C; - Post Stain Wash: 10 cycles of 4 mixes/cycle with Wash Buffer A at 30°C; - 2nd Stain Wash: Stain the probe array for 10 minutes in antibody solution at; 25°C; - 3rd Stain Wash: Stain the probe array for 10 minutes in SAPE solution at 25°C; - Final Wash: 15 cycles of 4 mixes/cycle with Wash Buffer A at 30°C. The; holding temperature is 25°C. Measurement of data and specifications:; Data transformation and selection procedures:; · The entire signals were scaled to 150 (4% capped median); scaling factors of the arrays were within 3.4 fold of each other, as the % genes called present were in the range of 23.7% and 38.1% for three arrays (GSM455889, GSM45589, GSM45591) and 74,4% for one array (GSM45590). The background levels (Average Background) were similar for all arrays (in a range of 47.20 and 55.64). The Q scores were comparable (in a range of 2.38 and 2.81). The Average Signals of the four arrays were similar (between 187.8 and 228.7). · Scanning hardware: AFFYMETRIX Scanner; software: AFFYMETRIX MAS 5 (Statistical Algorithms Reference Guide, http://www.affymetrix.com/support/technical/technotes/statistical_reference_guide.pdf), MICRO DB 3 and DMT 3; · Image analysis software: AFFYMETRIX MAS 5; Data selection:; · Threshold of Signal Log ratio: -1/1; change is I (increased), MI (marginally increased), D (decreased), MD (marginally decreased); change p-value >0.999 or <0.001; only genes that are present (Detection=P) in at least one of the compared chipsets. · Only following genes were considered: Minimal threshold of regulation ±2 fold; minimal change p-values of 0.999 and 0.001, respectively; minimal difference of signal intensities of 200. · The final gene expression data table used by the authors to make their conclusions after data selection and transformation will be published as supplementary data.

ORGANISM(S): Pseudomonas aeruginosa

SUBMITTER: Yusuf Nalca 

PROVIDER: E-GEOD-2430 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

Quorum-sensing antagonistic activities of azithromycin in Pseudomonas aeruginosa PAO1: a global approach.

Nalca Yusuf Y   Jänsch Lothar L   Bredenbruch Florian F   Geffers Robert R   Buer Jan J   Häussler Susanne S  

Antimicrobial agents and chemotherapy 20060501 5


The administration of macrolides such as azithromycin for chronic pulmonary infection of cystic fibrosis patients has been reported to be of benefit. Although the mechanisms of action remain obscure, anti-inflammatory effects as well as interference of the macrolide with Pseudomonas aeruginosa virulence factor production have been suggested to contribute to an improved clinical outcome. In this study we used a systematic approach and analyzed the impact of azithromycin on the global transcriptio  ...[more]

Similar Datasets

2006-05-10 | GSE2430 | GEO
2005-08-23 | GSE2336 | GEO
2015-12-23 | E-GEOD-74917 | biostudies-arrayexpress
2008-05-29 | GSE7968 | GEO
2008-02-22 | GSE9255 | GEO
2013-06-30 | E-GEOD-33160 | biostudies-arrayexpress
2021-09-05 | GSE152862 | GEO
2013-06-21 | E-GEOD-47173 | biostudies-arrayexpress
2008-06-19 | E-GEOD-7968 | biostudies-arrayexpress
2017-02-12 | GSE83078 | GEO